Arrowstreet Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $57.8M | Buy |
|
|||||
|
2025
Q2 | $15.7M | Buy |
|
|||||
|
2025
Q1 | $7.37M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $997K | Buy |
|
|||||
|
2024
Q2 | $479K | Sell |
|
|||||
|
2024
Q1 | $4.24M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $6.77M | Sell |
|
|||||
|
2023
Q1 | $7.75M | Buy |
|
|||||
|
2022
Q4 | $7.67M | Sell |
|
|||||
|
2022
Q3 | $22M | Buy |
|
|||||
|
2022
Q2 | $10.4M | Buy |
|
|||||
|
2022
Q1 | $9.03M | Sell |
|
|||||
|
2021
Q4 | $9.57M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.24M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.26M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.54M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $564K | Sell |
|
|||||
|
2013
Q3 | $1.17M | Buy |
|